Harmony Biosciences Holdings, Inc. (HRMY) Financial Statements (2026 and earlier)

Company Profile

Business Address 630 W GERMANTOWN PIKE
PLYMOUTH MEETING, PA 19462
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments775,340467,186353,460323,115234,309228,631
Cash and cash equivalent752,502453,001311,660243,784234,309228,631
Short-term investments22,83814,18541,80079,331  
Receivables96,78783,03374,14054,74034,84322,176
Inventory, net of allowances, customer advances and progress billings5,3577,1985,3634,2974,4323,823
Inventory5,3577,1985,3634,2974,4323,823
Prepaid expense16,01413,71412,5709,3477,6376,959
Other current assets13,5168,1215,5378,7863,2181,302
Total current assets:907,014579,252451,070400,285284,439262,891
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization  1,257371573820938
Long-term investments and receivables107,127108,87472,16922,568  
Long-term investments107,127108,87472,16922,568  
Intangible asset, including goodwill, after accumulated amortization89,418113,263137,108160,953143,919162,343
Intangible asset, excluding goodwill, after accumulated amortization89,418113,263137,108160,953143,919162,343
Restricted cash and investments  270270750750750
Deferred income tax assets149,699190,398144,16285,943  
Other noncurrent assets18,3735,8866,2982,7983,515152
Total noncurrent assets:364,617419,948360,378273,585149,004164,183
TOTAL ASSETS:1,271,631999,200811,448673,870433,443427,074
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities208,732134,38490,09963,72850,415134,225
Employee-related liabilities✕✕✕✕✕9,1658,942
Accounts payable17,69313,74417,7303,7861,0012,556
Accrued liabilities191,039120,64072,36959,94240,249122,727
Debt20,00016,25015,0002,0002,000 
Other liabilities4,9575,6727,8101,6241,360314
Other undisclosed current liabilities18,44318,77650,87211,532  
Total current liabilities:252,132175,082163,78178,88453,775134,539
Noncurrent Liabilities
Long-term debt and lease obligation143,663163,016178,566189,647189,984194,250
Long-term debt, excluding current maturities143,663163,016178,566189,647189,984194,250
Liabilities, other than long-term debt5,6181,9472,1092,5013,1771,105
Deferred rent credit      212
Other liabilities5,6181,9472,1092,5013,177893
Total noncurrent liabilities:149,281164,963180,675192,148193,161195,355
Total liabilities:401,413340,045344,456271,032246,936329,894
Equity
Equity, attributable to parent870,218659,155466,992402,838186,50797,180
Common stock111111
Additional paid in capital708,968656,872610,266675,118640,104585,374
Accumulated other comprehensive income (loss)346662(151)  
Retained earnings (accumulated deficit)160,9032,216(143,277)(272,130)(453,598)(488,195)
Total equity:870,218659,155466,992402,838186,50797,180
TOTAL LIABILITIES AND EQUITY:1,271,631999,200811,448673,870433,443427,074

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues868,453714,734582,022437,855305,440159,742
Cost of revenue
(Cost of Product and Service Sold)		(198,342)(156,815)(121,236)(83,481)(55,518)(27,738)
Gross profit:670,111557,919460,786354,374249,922132,004
Operating expenses(461,642)(367,093)(268,756)(234,188)(162,394)(115,018)
Operating income:208,469190,826192,030120,18687,52816,986
Nonoperating income (expense)21,24418,47414,88916916(3,071)
Investment income, nonoperating21,92418,54214,730   
Other nonoperating income (expense)(680)(68)15916916(3,071)
Interest and debt expense(14,649)(17,496)(33,523)(18,795)(26,146)(22,639)
Income (loss) from continuing operations before equity method investments, income taxes:215,064191,804173,396101,56061,398(8,724)
Other undisclosed income (loss) from continuing operations before income taxes    3,126(23,970)(28,220)
Income (loss) from continuing operations before income taxes:215,064191,804173,396104,68637,428(36,944)
Income tax expense (benefit)(56,377)(46,311)(44,543)76,782(2,831)4,436
Income (loss) from continuing operations:158,687145,493128,853181,46834,597(32,508)
Income (loss) before gain (loss) on sale of properties:✕✕✕✕✕34,597(32,508)
Other undisclosed net loss      (4,436)
Net income (loss) attributable to parent:158,687145,493128,853181,46834,597(36,944)
Preferred stock dividends and other adjustments      (26,904)
Net income (loss) available to common stockholders, diluted:158,687145,493128,853181,46834,597(63,848)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):158,687145,493128,853181,46834,597(36,944)
Comprehensive income (loss):158,687145,493128,853181,46834,597(36,944)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent28064153(151)  
Comprehensive income (loss), net of tax, attributable to parent:158,967145,557129,006181,31734,597(36,944)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: